HM
Hemlata Madanlal Sakhala
About Hemlata Madanlal Sakhala
Data last updated:
Hemlata Madanlal Sakhala is a Director at Maxheal Pharmaceuticals (India) Limited (since 2009) and Director at Maxheal Laboratories Private Limited (since 2004). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹152 Cr; the largest is Maxheal Pharmaceuticals (India) Limited at ₹82.41 Cr (FY 2024). Earlier, Hemlata Madanlal Sakhala was a Director at Ally Pharma Options Private Limited (from 2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maxheal Pharmaceuticals (India) Limited U73100MH2009PLC193624 | Director | 29 Jun 2009 | 2009 | ₹82.41 Cr (FY 2024) | Active |
| Maxheal Laboratories Private Limited U24230MH2004PTC150120 | Director | 21 Dec 2004 | 2004 | ₹69.71 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ally Pharma Options Private Limited U24230MH2003PTC138511 | Director | 14 Oct 2008 | 2003 | ₹39.79 Cr (FY 2015) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hemlata Madanlal Sakhala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Madanlal Mohanlal Sakhala | 00475606 | Maxheal Pharmaceuticals (India) Limited , Maxheal Laboratories Private Limited | Director |
| Mehul Madan Sakhala | 00475715 | Maxheal Pharmaceuticals (India) Limited , Maxheal Laboratories Private Limited | Managing Director |
| Pranita Mehul Sakhala | 07857189 | Maxheal Pharmaceuticals (India) Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemlata Madanlal Sakhala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemlata Madanlal Sakhala
Hemlata Madanlal Sakhala currently holds 2 directorships: Maxheal Pharmaceuticals (India) Limited (Director, since 29 Jun 2009, revenue ₹82.41 Cr (FY 2024)); Maxheal Laboratories Private Limited (Director, since 21 Dec 2004, revenue ₹69.71 Cr (FY 2025)).
Hemlata Madanlal Sakhala was first appointed on 21 Dec 2004 as Director at Maxheal Laboratories Private Limited. The most recent appointment on record is 29 Jun 2009 at Maxheal Pharmaceuticals (India) Limited.
The 2 current companies of Hemlata Madanlal Sakhala that report revenue have a combined latest revenue of ₹152 Cr: Maxheal Pharmaceuticals (India) Limited ₹82.41 Cr (FY 2024); Maxheal Laboratories Private Limited ₹69.71 Cr (FY 2025).
Hemlata Madanlal Sakhala held 1 earlier board appointment: Ally Pharma Options Private Limited (Director, from 14 Oct 2008).
The current boards of Hemlata Madanlal Sakhala's companies include Madanlal Mohanlal Sakhala (Maxheal Pharmaceuticals (India) Limited), Mehul Madan Sakhala (Maxheal Pharmaceuticals (India) Limited), Pranita Mehul Sakhala (Maxheal Pharmaceuticals (India) Limited).